FDA Law Blog: Biosimilars

JANUARY 18, 2024

Houck — In August 2023 the Food and Drug Administration (“FDA”) and Health and Human Services (“HHS”) recommended that the Drug Enforcement Administration (“DEA”) reschedule marijuana from schedule I under the federal Controlled Substances Act (“CSA”) to schedule III. HHS forwards FDA’s analysis and recommendation to DEA. 21 U.S.C. §

Controlled Substances 69

Controlled Substances Chemotherapy Compounding Dosage 69

FDA Law Blog: Biosimilars

FEBRUARY 11, 2024

Few would oppose FDA-approved marijuana-derived medications if marijuana compounds are found to have medical value; the National Institute of Health should continue to fund research on any potential medical value of marijuana and on the harms of highly potent products. January 29, 2024).

Controlled Substances 59

Controlled Substances Chemotherapy Compounding 59

Pharmacy Times

JUNE 5, 2025

1,2 New products are entering the market that could be poised to revolutionize the inventory counting process for pharmacists and health care providers, especially for controlled substances. Last Updated February 12, 2024. Pharmacy (Basel). 2020;8(4):216. doi:10.3390/pharmacy8040216 3. Tariq RA, Vashisht R, Sinha A, Scherbak Y.

Pharmacy Technician 26

Pharmacy Technician Packaging Labelling Immunity 26

The Thyroid Pharmacist

NOVEMBER 15, 2024

I also prefer semaglutide drugs over other weight loss drugs out there (for example, phentermine, a controlled substance that can be habit forming, or orlistat, a drug that results in fat malabsorption and “disaster pants”). Berberine Berberine is a natural compound found in several plants, including goldenseal and barberry.

Diabetes 83

Diabetes Immunity Immunization Compounding 83